Abstract
Objective: Uncooked cornstarch (UCCS) is used widely for the treatment of patients with glycogen storage disease type I (GSD-I). Previous studies suggested that glucose absorption may be impaired in GSD-I. In order to measure utilization of UCCS in young adults with GSD-Ia and healthy controls, we used a 13C-breath test based on the natural enrichment of 13C in UCCS. Design: Open, not randomized, prospective interventional study. Methods: Following 1 g/kg UCCS, we studied eight subjects with GSD-Ia (7 males, 1 female; mean age 28.3 years, range 16-42 years) and 15 healthy controls (10 males, 5 females; mean age 23.5 years, range 19-36 years). Breath samples for analysis of 13CO2 enrichment were collected at baseline and at 30-min intervals for 6 h or until hypoglycaemia occurred. Indirect calorimetry was used to measure respiratory gas exchange. Intermediate metabolites, lipids and glucose were measured in plasma. Breath H2 concentrations were measured as an indicator of malabsorption. Results: Cumulative utilization over 6 h was significantly higher in controls (18.35 ± 6.2% of total carbohydrate intake) than in subjects with GSD-Ia (11.5 ± 4.7%) (P< 0.02). However, utilization of UCCS was virtually identical up to 2.5 h. Two subjects with GSD-Ia fulfilled the criteria for malabsorption. Conclusions: Starch digestion and absorption are not impaired in GSD-Ia. However, overall utilization of UCCS appears to be lower in GSD-Ia, which is most likely secondary to perturbed intermediary metabolism. There are important implications for treatment of this disorder. Ways to improve the efficacy of UCCS in GSD-I are needed.
| Original language | English |
|---|---|
| Pages (from-to) | 1251-1256 |
| Number of pages | 6 |
| Journal | European Journal of Gastroenterology and Hepatology |
| Volume | 14 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2002 |
Fingerprint
Keywords
- Absorption
- Breath test
- Cornstarch
- Glycogen storage disease
- Isotope
ASJC Scopus subject areas
- Gastroenterology
Cite this
Utilization of cornstarch in glycogen storage disease type la. / Bodamer, Olaf A.; Feillet, Francois; Lane, Rebecca E.; Lee, Philip J.; Dixon, Marjorie A.; Halliday, Dave; Leonard, James V.
In: European Journal of Gastroenterology and Hepatology, Vol. 14, No. 11, 01.11.2002, p. 1251-1256.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Utilization of cornstarch in glycogen storage disease type la
AU - Bodamer, Olaf A.
AU - Feillet, Francois
AU - Lane, Rebecca E.
AU - Lee, Philip J.
AU - Dixon, Marjorie A.
AU - Halliday, Dave
AU - Leonard, James V.
PY - 2002/11/1
Y1 - 2002/11/1
N2 - Objective: Uncooked cornstarch (UCCS) is used widely for the treatment of patients with glycogen storage disease type I (GSD-I). Previous studies suggested that glucose absorption may be impaired in GSD-I. In order to measure utilization of UCCS in young adults with GSD-Ia and healthy controls, we used a 13C-breath test based on the natural enrichment of 13C in UCCS. Design: Open, not randomized, prospective interventional study. Methods: Following 1 g/kg UCCS, we studied eight subjects with GSD-Ia (7 males, 1 female; mean age 28.3 years, range 16-42 years) and 15 healthy controls (10 males, 5 females; mean age 23.5 years, range 19-36 years). Breath samples for analysis of 13CO2 enrichment were collected at baseline and at 30-min intervals for 6 h or until hypoglycaemia occurred. Indirect calorimetry was used to measure respiratory gas exchange. Intermediate metabolites, lipids and glucose were measured in plasma. Breath H2 concentrations were measured as an indicator of malabsorption. Results: Cumulative utilization over 6 h was significantly higher in controls (18.35 ± 6.2% of total carbohydrate intake) than in subjects with GSD-Ia (11.5 ± 4.7%) (P< 0.02). However, utilization of UCCS was virtually identical up to 2.5 h. Two subjects with GSD-Ia fulfilled the criteria for malabsorption. Conclusions: Starch digestion and absorption are not impaired in GSD-Ia. However, overall utilization of UCCS appears to be lower in GSD-Ia, which is most likely secondary to perturbed intermediary metabolism. There are important implications for treatment of this disorder. Ways to improve the efficacy of UCCS in GSD-I are needed.
AB - Objective: Uncooked cornstarch (UCCS) is used widely for the treatment of patients with glycogen storage disease type I (GSD-I). Previous studies suggested that glucose absorption may be impaired in GSD-I. In order to measure utilization of UCCS in young adults with GSD-Ia and healthy controls, we used a 13C-breath test based on the natural enrichment of 13C in UCCS. Design: Open, not randomized, prospective interventional study. Methods: Following 1 g/kg UCCS, we studied eight subjects with GSD-Ia (7 males, 1 female; mean age 28.3 years, range 16-42 years) and 15 healthy controls (10 males, 5 females; mean age 23.5 years, range 19-36 years). Breath samples for analysis of 13CO2 enrichment were collected at baseline and at 30-min intervals for 6 h or until hypoglycaemia occurred. Indirect calorimetry was used to measure respiratory gas exchange. Intermediate metabolites, lipids and glucose were measured in plasma. Breath H2 concentrations were measured as an indicator of malabsorption. Results: Cumulative utilization over 6 h was significantly higher in controls (18.35 ± 6.2% of total carbohydrate intake) than in subjects with GSD-Ia (11.5 ± 4.7%) (P< 0.02). However, utilization of UCCS was virtually identical up to 2.5 h. Two subjects with GSD-Ia fulfilled the criteria for malabsorption. Conclusions: Starch digestion and absorption are not impaired in GSD-Ia. However, overall utilization of UCCS appears to be lower in GSD-Ia, which is most likely secondary to perturbed intermediary metabolism. There are important implications for treatment of this disorder. Ways to improve the efficacy of UCCS in GSD-I are needed.
KW - Absorption
KW - Breath test
KW - Cornstarch
KW - Glycogen storage disease
KW - Isotope
UR - http://www.scopus.com/inward/record.url?scp=0036863099&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036863099&partnerID=8YFLogxK
U2 - 10.1097/00042737-200211000-00014
DO - 10.1097/00042737-200211000-00014
M3 - Article
C2 - 12439121
AN - SCOPUS:0036863099
VL - 14
SP - 1251
EP - 1256
JO - European Journal of Gastroenterology and Hepatology
JF - European Journal of Gastroenterology and Hepatology
SN - 0954-691X
IS - 11
ER -